Clinical Trial Management Systems Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2022 |
| CAGR (2024 - 2029) | 1.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Clinical Trial Management Systems Market Analysis
The Clinical Trial Management Systems Market is expected to register a CAGR of 1% during the forecast period.
Market growth is being driven by factors such as a surge in clinical trials addressing treatment and diagnosis needs, a response to the global increase in chronic diseases and lifestyle-related disorders, and the growing trend of outsourcing clinical trials to contract research organizations.
The global rise in chronic diseases, including diabetes, cancer, cardiovascular issues, and respiratory ailments, has significantly increased the demand for effective treatments. These chronic conditions often necessitate intricate trial designs, larger patient cohorts, and extended study durations. Such complexities demand robust management systems to oversee logistics, data handling, and regulatory adherence. For instance, the Canadian Cancer Statistics 2023 report highlighted a rise in new cancer cases in Canada, with 239.2 thousand reported in 2023, up from 233.9 thousand in 2022. Similarly, data from the Spanish Network of Cancer Registries (REDECAN) in January 2023 projected around 279,260 new cancer cases in Spain by the close of 2023. As cancer cases rise, so does the demand for its treatment, further amplifying the need for clinical trials and propelling market growth.
The increasing number of clinical trials necessitates efficient management solutions to streamline processes, monitor progress, and ensure regulatory compliance. For instance, data from ClinicalTrials.gov in October 2024 indicated approximately 512,338 ongoing clinical trials worldwide, with 153,133 based in the U.S. This robust engagement in clinical research, bolstered by heightened funding and government initiatives, underscores the anticipated demand for effective Clinical Trial Management Systems (CTMS) to oversee these activities, supporting market expansion.
Technological advancements aimed at reducing the rising costs associated with clinical trials have driven the evolution of clinical trial management systems. For instance, in May 2023, BSI Life Sciences launched BSI CTMS (Clinical Trial Management System) 7.0. This updated eClinical platform features over 50 enhancements, and an optimized user interface, and marks a significant milestone for the company. Notable features include advanced reporting tools, superior data integration, and enhanced user accessibility. Such innovations and launches in the CTMS realm are poised to drive market growth.
In summary, the escalating demand for drugs and medical devices, spurred by rising chronic diseases and the trend of outsourcing clinical trials, is set to fuel market growth. Yet, challenges like data security concerns and the high costs tied to clinical trial management systems could temper this expansion.
Clinical Trial Management Systems Market Trends
Software Segment is Expected to Hold a Significant Share Over the Forecast Period
A Clinical Trials Management System (CTMS) software serves as a pivotal tool, streamlining the planning, tracking, and oversight of clinical trials. It plays a crucial role in processes such as study design, site selection, patient recruitment, data collection, and ensuring regulatory compliance.
With the increasing need for effective clinical trial management, this segment is witnessing significant growth. Major drivers include the escalating prevalence of chronic diseases, prompting an increase in clinical trials for novel therapies, and the growing trend of outsourcing these trials to Contract Research Organizations (CROs) for enhanced efficiency and cost-effectiveness. Furthermore, the ongoing technological advancements, coupled with new software launches, are set to further propel this segment's growth.
As entities in clinical research increasingly acknowledge the importance of adept trial management, the uptake of CTMS software has surged. By leveraging CTMS, these entities can optimize processes such as patient recruitment, data oversight, and regulatory adherence, leading to expedited trial timelines and reduced operational expenses. For example, in March 2024, Oracle Corporation Japan announced that ONO PHARMACEUTICAL CO., LTD. has integrated Oracle’s Clinical Trial Management System (CTMS) Cloud Service. This decision is in line with ONO’s digital transformation (DX) agenda. With the CTMS, ONO gains the capability to oversee and manage clinical trial data globally from a centralized platform. This transition is projected to significantly ease ONO's system management responsibilities. As clinical trials grow in complexity, the adaptability and scalability of CTMS solutions position them as essential tools for organizations managing multiple trials, further fueling the segment's growth.
Leading players are persistently innovating their CTMS offerings, embedding cutting-edge features like artificial intelligence, machine learning, and data analytics to enhance decision-making and operational efficiency. For instance, in October 2024, CyberActa launched the EasyCLIN suite, a state-of-the-art clinical trial management software (CTMS), under the SynapCon GmbH brand in North America. EasyCLIN, with its unified database, bolstered the efficiency, compliance, and security of clinical trials for its clientele. Serving as a centralized hub for sponsors across pharmaceutical, biologics, and medical device trials, EasyCLIN facilitated clinical product development while upholding standards like EU GDPR, 21 CFR Part 11, and ICH GCP E6. Additionally, it augmented the value of regulatory documentation. Such strategic launches in the market are poised to amplify the adoption of CTMS, thereby bolstering the segment's growth trajectory.
In summary, the combination of technological advancements, increased software implementations, and new CTMS software launches is expected to drive demand and propel the segment's growth.
North America is Expected to Hold a Significant Market Share Over the Forecast Period
North America leads the clinical trial management systems market, driven by heightened investments in research and development and a growing demand for drug development.
As the number of trials rises, so does the demand for efficient management solutions to streamline processes, monitor progress, and ensure compliance, especially in North America. For instance, ClinicalTrials.gov reported that as of October 2023, North America had 195,130 ongoing clinical trials, with 176,684 based in the United States. This surge in studies and trials, combined with increased funding for clinical research, is poised to propel market growth.
Pharmaceutical and biotechnology firms are increasingly turning to specialized Contract Research Organizations (CROs) for their clinical trials. This outsourcing fosters deeper collaboration between sponsors and CROs, underscoring the need for effective CTMS to enhance communication, data sharing, and project management. For instance, in August 2024, BSI Life Sciences, in partnership with Zelta by Merative, announced that Worldwide Clinical Trials has adopted its Clinical Trial Management System (BSI CTMS). Worldwide Clinical Trials, a global full-service CRO, partners with biotech and pharmaceutical companies, offering customized solutions to advance new medications. Their expertise spans neuroscience, oncology, rare diseases, and both cardiometabolic and inflammatory conditions. As CROs broaden their services, the demand for scalable and flexible CTMS solutions to concurrently manage an increasing number of trials intensifies.
Active participation from diverse market players, including software developers, CROs, and pharmaceutical firms, is a significant driver for the growth of the CTMS software segment. For instance, in February 2023, Suvoda unveiled a specialized software platform, integrating proven technological innovations into clinical trial management, aiming to simplify complexities and mitigate risks throughout the trial process.
Given these dynamics, the market is poised for growth in the coming years, fueled by escalating R&D investments and a surging demand for drug development.
Clinical Trial Management Systems Industry Overview
The clinical trials management system market is consolidated in nature due to the presence of limited companies operating globally and regionally. Key players operating in the target industry are ArisGlobal LLC, Bioclinica, Advarra, DATATRAK International Inc., DZS Clinical Services, ERT Clinical, IBM, Dassault Systèmes (Medidata Solutions Inc.), MedNet Solutions Inc., Oracle, Calyx, RealTime Software Solutions LLC, and Veeva Systems.
Clinical Trial Management Systems Market Leaders
-
MedNet Solutions Inc.
-
IBM
-
Calyx
-
Oracle
-
Advarra
*Disclaimer: Major Players sorted in no particular order
Clinical Trial Management Systems Market News
- October 2024: Pharmaseal, a trial management software firm entered into a partnership with Ledger Run, a tech company dedicated to refining clinical operations. Their collaboration seeks to optimize clinical trial budgeting and payment processes through their respective platforms, Engility and ClinRun.
- October 2024: Octalsoft, a prominent player in the Clinical Trial Management Systems (CTMS) arena, has unveiled its cutting-edge Quality Assurance (QA) module. This state-of-the-art module aims to optimize and elevate quality management processes in clinical trials. It boasts a suite of features, including audit plan generation, creation of audit reports with observations, management of Corrective and Preventive Actions (CAPA), and thorough compliance tracking.
Clinical Trial Management Systems Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Number of Clinical Trials Due to Rising Chronic Diseases and Lifestyle-related Disorders
4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
4.3 Market Restraints
4.3.1 Data Security Issues
4.3.2 High Cost Associated With Clinical Trial Management Systems
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Delivery Mode
5.1.1 On-premise
5.1.2 Cloud-based
5.2 By Component
5.2.1 Software
5.2.2 Services
5.3 By End User
5.3.1 Pharmaceuticals
5.3.2 Contract Research Organization
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ArisGlobal LLC
6.1.2 Bioclinica
6.1.3 DATATRAK International Inc.
6.1.4 Advarra
6.1.5 DZS Clinical Services
6.1.6 ERT Clinical
6.1.7 IBM
6.1.8 Dassault Systèmes (Medidata Solutions Inc.)
6.1.9 MedNet Solutions Inc.
6.1.10 Oracle Corporation
6.1.11 Calyx
6.1.12 RealTime Software Solutions LLC
6.1.13 Veeva Systems
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Clinical Trial Management Systems Industry Segmentation
A clinical trial management system is a software system used to manage trials in clinical research. The system maintains and manages the planning, performance, and reporting functions, along with participants' contact information and tracking deadlines, milestones, and services.
The clinical trial management systems market is segmented by delivery mode, component, end-user, and geography. By delivery mode, the market is segmented into on-premise and cloud-based. By component, the market is segmented into software and services. By end-user, the market is segmented into pharmaceuticals, clinical research organizations, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Delivery Mode | |
| On-premise | |
| Cloud-based |
| By Component | |
| Software | |
| Services |
| By End User | |
| Pharmaceuticals | |
| Contract Research Organization | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Clinical Trial Management Systems Market Research FAQs
What is the current Clinical Trial Management Systems Market size?
The Clinical Trial Management Systems Market is projected to register a CAGR of 1% during the forecast period (2023-2029)
Who are the key players in Clinical Trial Management Systems Market?
MedNet Solutions Inc., IBM, Calyx, Oracle and Advarra are the major companies operating in the Clinical Trial Management Systems Market.
Which is the fastest growing region in Clinical Trial Management Systems Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2029).
Which region has the biggest share in Clinical Trial Management Systems Market?
In 2023, the North America accounts for the largest market share in Clinical Trial Management Systems Market.
What years does this Clinical Trial Management Systems Market cover?
The report covers the Clinical Trial Management Systems Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Trial Management Systems Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Clinical Trial Management Systems Industry Report
Statistics for the 2024 Clinical Trial Management System market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clinical Trial Management System analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
